Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24525N0615
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $13,168
Award facts
- Contract value 100% obligated
- $13,168.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc., a specialty pharmaceutical manufacturer headquartered in Rockville, Maryland, has been awarded a delivery order valued at $13,168.39 for JYNARQUE (tolvaptan) 90mg-30mg tablets by Veterans Integrated Service Network 5. This firm-fixed-price contract, awarded on April 30, 2025, with completion by May 2, 2025, supports the Department of Veterans Affairs' delivery of pharmaceutical treatments to veteran patients in the Pittsburgh, Pennsylvania area. The contract does not utilize a set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), reflecting Otsuka's established status as a qualified supplier of specialty medications to the VA healthcare system.
This delivery order is executed under Otsuka's broader Blanket Purchase Agreement with the VA's National Acquisition Center, valued at $83.3 million with completion through March 26, 2026, which enables efficient procurement of JYNARQUE across multiple VA Integrated Service Networks. JYNARQUE is indicated for the treatment of autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The company's $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products further demonstrates its capacity to support the VA's comprehensive healthcare mission nationwide, with delivery orders typically ranging from $10,000 to $113,000 across various VA Integrated Service Networks.
Quick answers
Who was awarded contract 36C24525N0615?
36C24525N0615 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 30, 2025.
How much is contract 36C24525N0615 worth?
The government has obligated $13,168 on 36C24525N0615.
Is contract 36C24525N0615 an order under another contract?
Yes. 36C24525N0615 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0615 competed?
The extent of competition for 36C24525N0615 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award